Exclusive

Publication

Byline

Macrogen inks license and supply agreement with Thermo Fisher

Kap, Jan. 14 -- Seok Yang, CEO of Macrogen has announced that the company has signed a strategic License and Supply Agreement with Thermo Fisher Scientific. The agreement, which was recently signed, a... Read More


NUS develops reusable sweat pH monitor

Singapore, Jan. 14 -- Sweat, which contains a wide range of biochemical markers, can tell us a lot about our health. Variations in sweat pH (i.e. acidity or alkalinity), for instance, can tell us whet... Read More


ERS Genomics licenses CRISPR gene editing technology to Daiichi Sankyo

Singapore, Jan. 14 -- ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, has announced the sig... Read More


EUSA Pharma, BeiGene partner for rare disease drug development

Singapore, Jan. 14 -- EUSA Pharma and BeiGene has announced that they have entered into an exclusive development and commercialization agreement for the orphan biologic products SYLVANT (siltuximab) a... Read More


WuXi AT expands service capabilities

Singapore, Jan. 14 -- US based WuXi Advanced Therapies (AT), a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advance therapies... Read More


Great Bay Bio injected with $2.5M of convertible note

Singapore, Jan. 14 -- Recently, Great Bay Bio signed off convertible note, and the company will be injected with 2.5 million USD by existing shareholders, which including renowned financial institute ... Read More


Asia-Pacific has record year for clinical trials according to Novotech CRO

Singapore, Jan. 14 -- Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for the number of studies, experienced world-class sites and investigators, and pat... Read More


Agilex Biolabs announces new pharmacodynamics services

Award, Jan. 14 -- winning Agilex Biolabs, the Asia-Pacific region's leading bioanalytical laboratory based in Australia, announced a raft of new pharmacodynamics services for biotech and pharma client... Read More


Genome & Company inks clinical trial collaboration and supply agreement

Singapore, Jan. 14 -- Genome & Company on 14 Jan 2020 announced that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc. to eval... Read More


BioMed X Starts Schizophrenia Research Program with Boehringer Ingelheim

Singapore, Jan. 14 -- BioMed X on 13 Jan 2020 announced the start of a new joint research group in collaboration with Boehringer Ingelheim at the BioMed X Innovation Center in Heidelberg. The aim of t... Read More